Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer

NCT03448458 PHASE2 COMPLETED Results posted

This pilot clinical trial studies how well gallium Ga 68-DOTATATE positron emission tomography (PET)/computed tomography (CT) works in treating patients with castration resistant prostate cancer that has spread to other placed in the body. Gallium Ga 68-DOTATATE PET/CT may help doctors to identify those patients with early neuroendocrine transdifferentiation and who are at greater risk for poor outcomes.

Details

Lead sponsor	Emory University
Phase	PHASE2
Status	COMPLETED
Enrolment	17
Start date	Thu Feb 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Castration-Resistant Prostate Carcinoma
• Metastatic Prostate Carcinoma
• Stage IV Prostate Cancer AJCC v7

Interventions

• CT (Computed Tomography)
• Gallium Ga 68-DOTATATE
• Positron Emission Tomography

Countries

United States